Increased enamel hypoplasia and very low birthweight infants

S Nelson1, J M Albert, C Geng

  • 1Department of Community Dentistry, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. sxn15@case.edu

Insights

Very low birthweight (VLBW) infants show higher enamel hypoplasia risk. Early childhood caries (ECC) incidence was similar between VLBW and normal birthweight infants, but VLBW infants need ECC monitoring due to hypoplasia.

Area of Science:

  • Pediatric Dentistry
  • Neonatal Health
  • Dental Public Health

Background:

  • Birth cohort studies on enamel defects and early childhood caries in very low birthweight (VLBW) infants are scarce.
  • Developmental defects of enamel (DDE) and early childhood caries (ECC) can impact long-term oral health.
  • VLBW infants represent a population at potential risk for dental anomalies.

Purpose of the Study:

  • To compare the incidence of ECC and DDE in VLBW and normal birthweight (NBW) infants.
  • To identify risk factors for DDE and ECC in these cohorts.
  • To inform monitoring strategies for VLBW infants.

Main Methods:

  • A birth cohort study involving 234 VLBW and 234 NBW infants.
  • Dental assessments for ECC and DDE (enamel hypoplasia, demarcated and diffuse opacities) at 8 and 18-20 months corrected age.
  • Beta-binomial regression analysis to control for confounders.

Main Results:

  • Enamel hypoplasia incidence was significantly higher in VLBW infants (19% at 8 mos, 31% at 18 mos) compared to NBW infants (2% at 8 mos, 8% at 18 mos).
  • ECC incidence (ICDAS ≥ 2) was 1.4% at 8 months and 12% at 18-20 months, with no significant difference between VLBW and NBW groups.
  • VLBW infants demonstrated an increased risk for enamel hypoplasia, even after controlling for maternal and infant characteristics.

Conclusions:

  • VLBW infants are at a higher risk for enamel hypoplasia.
  • Despite similar ECC rates, VLBW infants with enamel hypoplasia require close monitoring for early childhood caries.
  • Targeted dental surveillance is crucial for VLBW infants to prevent ECC progression.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Teeth01:15

Teeth

The formation of teeth, also known as odontogenesis, is a complex process that begins in utero, around the sixth week of embryonic development. There are three stages to this process: the bud stage, the cap stage, and the bell stage.
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin and...